Is the LION strong enough?

Future Oncol. 2017 Sep;13(21):1835-1837. doi: 10.2217/fon-2017-0292. Epub 2017 Aug 9.

Authors

David Atallah¹, Elie El Rassy², Georges Chahine²

Affiliations

¹ Department of Gynecology & Obstetrics, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Lebanon.
² Department of Medical Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Lebanon.

PMID: 28792242
DOI: 10.2217/fon-2017-0292

No abstract available

Keywords: LION trial; advanced ovarian cancer; lymphadenectomy; residual disease.

Publication types

Editorial

MeSH terms

Clinical Trials as Topic
Combined Modality Therapy
Female
Humans
Lymph Node Excision* / methods
Lymphatic Metastasis
Neoplasm Staging
Ovarian Neoplasms / mortality
Ovarian Neoplasms / pathology*
Ovarian Neoplasms / surgery*
Ovarian Neoplasms / therapy
Pelvis
Randomized Controlled Trials as Topic
Treatment Outcome